Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Electrostatic Dissipative Feature Augments New Line of Ductless Fume Hoods

By LabMedica International staff writers
Posted on 13 Aug 2013
A new line of fume hoods that promises laboratory workers superior protection against buildup of toxic fumes has been combined with electrostatic dissipative features to prevent static buildup and discharge.

Aura ductless fume hoods manufactured by Mystaire Misonix (Creedmoor, NC, USA) are self-contained, filtered enclosures that remove hazardous fumes, vapors, and particles from virtually any laboratory application. More...
Unlike traditional fume hoods, there are no installation costs and no ductwork is needed. The new Aura ESD line of hoods adds an electrostatic dissipation feature to the state-of-the art Aura line.

Each Aura ductless fume hood has advanced safety monitoring and controls including the EverSafe II microprocessor safety controller, which monitors and adjusts fume hood face velocity to a user-preset value. EverSafe II maintains face velocity at the proper rate for containment of potentially toxic gases and vapors.

The US made Aura fume hoods, which are available in 72.6 centimeter, 106.68 centimeter, and 137.16-centimeter widths have been ASHRAE (American Society of Heating, Refrigerating and Air Conditioning Engineers) 110 tested and provide excellent containment from toxic fumes and vapors. The Filtrak positive filter sealing system installed in each Aura ductless hood is a cam-driven filter sealing system with a built-in filter position indicator and an alert that informs the user if the filtration bed is not properly sealed. The Filtrak system enables safe and easy filter maintenance and replacement.

Related Links:
Mystaire Misonix



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.